CI
Cresilon, Inc.
SEC filingBiotechnology · Brooklyn, NY
Amount raised$29Msold at filing
Total offering$29M$801 still open
Investors in the raise217count reported to the SEC
FiledJun 26, 2026first sale Apr 24, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Joseph LandolinaExecutive Officer, Director
Isaac MillerDirector
Scott LevineExecutive Officer
Executive officers, directors and promoters as listed on the Form D.